CEL-SCI Corp

Company Profile

CEL-SCI Corp had its IPO on 1987-01-01 under the ticker symbol CVM.

The company operates in the Healthcare sector and Biotechnology industry. CEL-SCI Corp has a staff strength of 0 employees.

Stock update

Shares of CEL-SCI Corp opened at $1.26 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.22 - $1.27, and closed at $1.23.

This is a -0.81% slip from the previous day's closing price.

A total volume of 125,347 shares were traded at the close of the day’s session.

In the last one week, shares of CEL-SCI Corp have slipped by -11.51%.

CEL-SCI Corp's Key Ratios

CEL-SCI Corp has a market cap of $114.02 million, indicating a price to book ratio of 2.6763 and a price to sales ratio of 11797.424.

In the last 12-months CEL-SCI Corp’s revenue was $28558 with a gross profit of $-25355346 and an EBITDA of $-29558648. The EBITDA ratio measures CEL-SCI Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CEL-SCI Corp’s operating margin was 0% while its return on assets stood at -40.9% with a return of equity of -108.44%.

In Q1, CEL-SCI Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 62.7%.

CEL-SCI Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.83 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CEL-SCI Corp’s profitability.

CEL-SCI Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -2.9179. Its price to sales ratio in the trailing 12-months stood at 11797.424.

CEL-SCI Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$38.20 million

Total Liabilities

$5.31 million

Operating Cash Flow

$-111452.00

Capital Expenditure

$111452

Dividend Payout Ratio

0%

CEL-SCI Corp ended 2024 with $38.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $38.20 million while shareholder equity stood at $20.15 million.

CEL-SCI Corp ended 2024 with $0 in deferred long-term liabilities, $5.31 million in other current liabilities, 437878.00 in common stock, $-471093411.00 in retained earnings and $0 in goodwill. Its cash balance stood at $10.05 million and cash and short-term investments were $10.05 million. The company’s total short-term debt was $1,849,749 while long-term debt stood at $0.

CEL-SCI Corp’s total current assets stands at $12.57 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.89 million and inventory worth $1.89 million.

In 2024, CEL-SCI Corp's operating cash flow was $-111452.00 while its capital expenditure stood at $111452.

Comparatively, CEL-SCI Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.23

52-Week High

$5.42

52-Week Low

$1.86

Analyst Target Price

$10.5

CEL-SCI Corp stock is currently trading at $1.23 per share. It touched a 52-week high of $5.42 and a 52-week low of $5.42. Analysts tracking the stock have a 12-month average target price of $10.5.

Its 50-day moving average was $1.69 and 200-day moving average was $2.3 The short ratio stood at 17.12 indicating a short percent outstanding of 0%.

Around 388.9% of the company’s stock are held by insiders while 1378.4% are held by institutions.